643 related articles for article (PubMed ID: 21606084)
1. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
[TBL] [Abstract][Full Text] [Related]
2. Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation.
Brignole M; Botto GL; Mont L; Oddone D; Iacopino S; De Marchi G; Campoli M; Sebastiani V; Vincenti A; Garcia Medina D; Osca Asensi J; Mocini A; Grovale N; De Santo T; Menozzi C
Heart; 2012 Feb; 98(4):297-302. PubMed ID: 22095616
[TBL] [Abstract][Full Text] [Related]
3. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
Stavrakis S; Garabelli P; Reynolds DW
Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
Rönn F; Kesek M; Karp K; Henein M; Jensen SM
Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
[TBL] [Abstract][Full Text] [Related]
6. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
[TBL] [Abstract][Full Text] [Related]
7. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
[TBL] [Abstract][Full Text] [Related]
8. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
[TBL] [Abstract][Full Text] [Related]
9. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.
Brignole M; Pokushalov E; Pentimalli F; Palmisano P; Chieffo E; Occhetta E; Quartieri F; Calò L; Ungar A; Mont L;
Eur Heart J; 2018 Dec; 39(45):3999-4008. PubMed ID: 30165479
[TBL] [Abstract][Full Text] [Related]
11. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
[TBL] [Abstract][Full Text] [Related]
12. Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy.
Tolosana JM; Trucco E; Khatib M; Doltra A; Borras R; Castel MÁ; Berruezo A; Arbelo E; Sitges M; Matas M; Guasch E; Brugada J; Mont L
Eur J Heart Fail; 2013 Dec; 15(12):1412-8. PubMed ID: 23845796
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
14. Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF).
Stockburger M; Gómez-Doblas JJ; Lamas G; Alzueta J; Fernández-Lozano I; Cobo E; Wiegand U; Concha JF; Navarro X; Navarro-López F; de Teresa E
Eur J Heart Fail; 2011 Jun; 13(6):633-41. PubMed ID: 21613427
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of long-term right ventricular apical pacing and identification of patients at risk of atrial fibrillation and heart failure.
De Sisti A; Márquez MF; Tonet J; Bonny A; Frank R; Hidden-Lucet F
Pacing Clin Electrophysiol; 2012 Aug; 35(8):1035-43. PubMed ID: 22452247
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).
Doshi RN; Daoud EG; Fellows C; Turk K; Duran A; Hamdan MH; Pires LA;
J Cardiovasc Electrophysiol; 2005 Nov; 16(11):1160-5. PubMed ID: 16302897
[TBL] [Abstract][Full Text] [Related]
17. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.
Tan ES; Rienstra M; Wiesfeld AC; Schoonderwoerd BA; Hobbel HH; Van Gelder IC
Europace; 2008 Apr; 10(4):412-8. PubMed ID: 18272509
[TBL] [Abstract][Full Text] [Related]
19. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
[TBL] [Abstract][Full Text] [Related]
20. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
